Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.

Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients. - Metabolic change by SGLT2 inhibitors.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015057

Enrollment

Registered

2014-09-04

Start date

2014-08-19

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

SGLT2 inhibitors

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1. severe ketosis, diabetic coma, or before coma 2. before and not long after surgery,or patients with severe trauma 3. alcohol intake's excessive 4. patients who have a fever of 37.0 degrees or more 5. obvious infection 6. severe renal dysfunction or dialysis patients 7. patients with symptoms of urinary retention, difficulty urinating, anuria, or oliguria 8. severe liver dysfunction 9. patients with obvious active malignant tumor 10. women suspected of pregnancy or pregnant 11. patients with a history of use SGLT2 inhibitors

Design outcomes

Primary

Measure	Time frame
Body composition Glucose profile Nitrogen balance	—

Secondary

Measure	Time frame
Body weight Glycated hemoglobin Glycated albumin Lipid profile Urinary albumin excretion Urinary protein excretion	—

Countries

Japan

Contacts

Public ContactTAKAHIRO YAMAGISHI

Kitasato University School of Medicine Endocrinology and Metabolism

yamagishi@med.kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026